Page last updated: 2024-10-31

midazolam and Laryngeal Diseases

midazolam has been researched along with Laryngeal Diseases in 1 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Laryngeal Diseases: Pathological processes involving any part of the LARYNX which coordinates many functions such as voice production, breathing, swallowing, and coughing.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baldwin, MK1
Benumof, JL1

Other Studies

1 other study available for midazolam and Laryngeal Diseases

ArticleYear
Paradoxical vocal cord movement: a unique case of occurrence and treatment.
    Anesthesiology, 2007, Volume: 107, Issue:2

    Topics: Adult; Anesthetics, Intravenous; Botulinum Toxins, Type A; Female; Humans; Intubation, Intratracheal

2007